Despite the small size of our sample, we suggest that MDM2 immunohistochemical expression may have a prognostic significance in GIST, and this fact emphasizes the need for large studies to show the exact prognostic value of MDM2 oncoprotein. This evidence concerns the gene MDM2 and gastrointestinal stromal tumor.